Bundamedik Tbk PT (BMHS)

Currency in IDR
189
-2(-1.05%)
Closed·
BMHS Scorecard
Full Analysis
Net income is expected to grow this year
BMHS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
187192
52 wk Range
185360
Key Statistics
Bid/Ask
188.00 / 189.00
Prev. Close
191
Open
192
Day's Range
187-192
52 wk Range
185-360
Volume
3.01M
Average Volume (3m)
2.5M
1-Year Change
-37%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BMHS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
220
Upside
+16.40%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Bundamedik Tbk PT Company Profile

PT Bundamedik Tbk provides health care services in Indonesia. It also engages in the wholesale and distribution of drugs, pharmaceuticals, and medical equipment; private hospital and healthcare support service activities; provision of ambulance services; private health education; consultant for reproductive technology services management; management consultant of physiotherapy service; and hotel, medical tourism, and management consulting businesses. It operates maternal and children hospitals, general hospitals, cardiovascular hospitals, clinics, IVF clinics, and diagnostic laboratories. PT Bundamedik Tbk was founded in 1973 and is headquartered in Jakarta Pusat, Indonesia. PT Bunda Medik is a subsidiary of PT Bunda Investama Indonesia.

Compare BMHS to Peers and Sector

Metrics to compare
BMHS
Peers
Sector
Relationship
P/E Ratio
333.0x9.3x−0.6x
PEG Ratio
−5.080.070.00
Price/Book
1.0x1.1x2.6x
Price / LTM Sales
1.1x0.7x3.3x
Upside (Analyst Target)
16.4%7.6%40.2%
Fair Value Upside
Unlock28.0%5.1%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 220
(+16.40% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.57%
Dividend Yield
0.34%
Industry Median 1.17%
Annualised payout
0.65
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Jul 31, 2025
EPS / Forecast
0.09 / --
Revenue / Forecast
378.77B / --
EPS Revisions
Last 90 days

BMHS Income Statement

FAQ

What Stock Exchange Does Bundamedik Tbk PT Trade On?

Bundamedik Tbk PT is listed and trades on the Jakarta Stock Exchange stock exchange.

What Is the Stock Symbol for Bundamedik Tbk PT?

The stock symbol for Bundamedik Tbk PT is "BMHS."

What Is the Bundamedik Tbk PT Market Cap?

As of today, Bundamedik Tbk PT market cap is 1.63T.

What Is Bundamedik Tbk PT's Earnings Per Share (TTM)?

The Bundamedik Tbk PT EPS (TTM) is 0.57.

When Is the Next Bundamedik Tbk PT Earnings Date?

Bundamedik Tbk PT will release its next earnings report on 03 Nov 2025.

From a Technical Analysis Perspective, Is BMHS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Bundamedik Tbk PT Stock Split?

Bundamedik Tbk PT has split 0 times.

How Many Employees Does Bundamedik Tbk PT Have?

Bundamedik Tbk PT has 1555 employees.

What is the current trading status of Bundamedik Tbk PT (BMHS)?

As of 18 Aug 2025, Bundamedik Tbk PT (BMHS) is trading at a price of 189.00, with a previous close of 191.00. The stock has fluctuated within a day range of 187.00 to 192.00, while its 52-week range spans from 185.00 to 360.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.